Peking University
Clinical trials sponsored by Peking University, explained in plain language.
-
AI-Powered app teams with doctors to fight diabetes
Disease control Not yet recruitingThis study is testing whether a smartphone app that uses artificial intelligence (AI) can help people better manage their type 2 diabetes when used alongside their regular doctor. About 1,200 adults in China will use the app to take pictures of their meals for AI feedback and get…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough liver cancers: testing a powerful Three-Pronged attack
Disease control Not yet recruitingThis study aims to see if adding a targeted liver chemotherapy infusion (HAIC) to a standard two-drug regimen (lenvatinib and a PD-1 inhibitor) works better for people with advanced liver cancer that has grown into major blood vessels or bile ducts. It will enroll 150 patients wh…
Sponsor: Peking University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors test Direct-Abdominal treatment for tough stomach cancer
Disease control Not yet recruitingThis early-stage study is testing whether a new combination of two drugs, delivered directly into the abdomen, is safe and tolerable for patients with a specific type of advanced stomach cancer that has spread to the abdominal lining. The main goal is to find the highest dose pat…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug enters first human trials
Disease control Not yet recruitingThis is the first study testing a new cancer drug called SIG001 in people. Researchers want to find the safest dose for patients with advanced solid tumors that haven't responded to standard treatments. The study will enroll 66 patients who will receive the drug through an IV eve…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Targeted liver chemo shows promise as potent alternative for Tough-to-Treat bile duct cancer
Disease control Not yet recruitingThis study is testing a two-part treatment for advanced bile duct cancer, which is often found too late for surgery. It combines a strong, targeted chemotherapy infusion directly into the liver with standard cancer drugs given through the bloodstream. The goal is to see if this a…
Sponsor: Peking University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Simple salt swap could protect moms from dangerous pregnancy condition
Prevention Not yet recruitingThis study is testing whether replacing regular salt with a low-sodium alternative can safely prevent dangerous high blood pressure disorders during pregnancy. It will involve about 3,200 pregnant women in China who are at high risk for these conditions. Participants will be rand…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Mar 16, 2026 15:26 UTC
-
Can a phone app help kids stay healthy? major study launches
Prevention Not yet recruitingThis study is testing a new digital program designed to prevent obesity in children. It uses a WeChat platform to deliver personalized tips and support to kids and their parents about healthy eating and physical activity. Researchers will compare children using the program to tho…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Mar 05, 2026 13:59 UTC
-
Can computer games slow memory decline? new study tests different 'Doses'
Symptom relief Not yet recruitingThis study aims to find out if different amounts of computer-based brain training can help improve thinking skills in older adults with mild memory problems. Researchers will test various schedules of training over 12 weeks to see which amount works best. They will also check if …
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Apr 02, 2026 05:40 UTC